LINCTOBC

Serial Number 79332438
Registration 7220365
700

Registration Progress

Application Filed
Nov 17, 2021
Under Examination
Approved for Publication
Sep 5, 2023
Published for Opposition
Sep 5, 2023
Registered
Nov 21, 2023

Basic Information

Serial Number
79332438
Registration Number
7220365
Filing Date
November 17, 2021
Registration Date
November 21, 2023
Published for Opposition
September 5, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 21, 2023
Registration
Registered
Classes
009 042 044

Rights Holder

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

99
Address
101 rue de Tolbiac
F-75013 PARIS
FR

Ownership History

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Original Applicant
99
FR

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Owner at Publication
99
FR

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Original Registrant
99
FR

Legal Representation

Attorney
Cathleen E. Stadecker

USPTO Deadlines

Next Renewal Deadline
1597 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-11-21)
Due Date
November 21, 2029
Grace Period Ends
May 21, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description
Nov 22, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Mar 26, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2024 XXSS O GENERIC MADRID TRANSACTION SENT TO IB
Feb 22, 2024 XXCR P GENERIC MADRID TRANSACTION CREATED
Feb 21, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 21, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 21, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 5, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 PUBO A PUBLISHED FOR OPPOSITION
Sep 4, 2023 GPNX P NOTIFICATION PROCESSED BY IB
Aug 16, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 16, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 1, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 5, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 5, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 26, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 19, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 19, 2023 GNFR O FINAL REFUSAL E-MAILED
Apr 19, 2023 CNFR R FINAL REFUSAL WRITTEN
Mar 30, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2022 RFNT P REFUSAL PROCESSED BY IB
Oct 20, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 20, 2022 RFRR P REFUSAL PROCESSED BY MPU
Aug 27, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 26, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 22, 2022 DOCK D ASSIGNED TO EXAMINER
Feb 8, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Feb 4, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 009
Scientific and research apparatus and instruments in the field of health, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor, prisms for scientific and medical research purposes; Recorded software for diagnosing the risk of developing breast cancer; Downloadable computer application software for mobile phones and handheld computers for diagnosing the risk of developing breast cancer; Downloadable computer software for diagnosing the risk of developing breast cancer and downloadable computer application software for mobile devices for diagnosing the risk of developing breast cancer; Downloadable computer software platforms for diagnosing the risk of developing breast cancer and downloadable mobile application software for diagnosing the risk of developing breast cancer; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy
Class 042
Scientific research services for medical purposes in the field of breast cancer therapy; Medical research; Design, development, maintenance and updating of computer software; Development of computer platforms; Computer system design; Computer programming; Electronic data storage; Computer software consultancy; Software as a service (SaaS) services featuring software for diagnosing the risk of developing breast cancer; Platform as a service (PaaS) featuring computer software platforms for diagnosing the risk of developing breast cancer; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy
Class 044
Health services, namely, oncologic health care; Medical services; Therapeutic services, namely, radiotherapeutic agent therapy, immunotherapeutic agent therapy, chemotherapeutic agent therapy services and surgery; Medical assistance; Medical clinic services and medical analysis services provided by medical laboratories for diagnostic and therapeutic treatment purposes; Advice regarding health; Telemedicine services; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy

Additional Information

Pseudo Mark
LINC TO BC; LINK TO BC; LINC TO BREAST CANCER; LINK TO BREAST CANCER

Classification

International Classes
009 042 044